Arbutus Biopharma Corporation
ABUS
|
$2.73
-1.8%
-1.83%
1M
|
Health Technology
(0.0% 1d) (15.4% 1m) (-2.7% 1y) (0.0% 2d) (0.0% 3d) (0.3% 7d) (NaN% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 490,013,703
http://www.arbutusbio.com
Sec Filling | Patents | 80 employees
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis injection
add to watch list Paper trade email alert is off
Press-releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -5.82%
H: 0.0%
C: 0.0%
first report update financial results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 1.46%
H: 3.2%
C: -0.41%
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 16.73%
H: 6.14%
C: 2.39%
patent construction biopharma ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -1.58%
H: 3.05%
C: 2.41%
year update financial results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Arbutus to Participate in Two Upcoming Investor Conferences
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
ROIV | $10.37 -0.67% -0.68% 3.4M
|
Manufacturing
|
| O: 1.2%
H: 0.34%
C: -3.46%
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -2.44%
year update financial results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: -1.36%
report year update financial results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 3.32%
H: 3.21%
C: -1.61%
update financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
hbv003 biopharma collaboration trial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
SNDA P 3000 | $29.61 3.35% 0.0% 30K
|
n/a
|
22:00
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
FAST P 3350 | $67.5 -1.43% -1.45% 3.6M
|
Distribution Services
|
20:00
QCRH | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
RVP P 15363 | $1.05 0.96% 0.0% 120K
|
Health Technology
|
18:00
VUZI | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
TPL P 3 | $582.4 -0.44% 0.0% 63K
|
Miscellaneous
|
15:00
RELL | $10.15 2.94% 2.86% 94K
|
Electronic Technology
|
13:30
IZEA | $2.65 4.74% 4.53% 31K
|
Technology Services
|
00:00
RKT P 383 | $11.53 1.32% 0.0% 1.6M
|
Finance
|
22:30
CTRN P 18090 | $22.28 -0.4% -0.4% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% -0.36% 54K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.94 -1.65% -1.68% 2.9M
|
Health Technology
|
16:30
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10